SOPHiA GENETICS (SOPH)
(Delayed Data from NSDQ)
$5.06 USD
0.00 (0.00%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $5.01 -0.05 (-0.99%) 7:58 PM ET
4-Sell of 5 4
F Value C Growth A Momentum D VGM
SOPHiA GENETICS SA (SOPH) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$8.33 | $10.00 | $7.00 | 64.62% |
Price Target
Based on short-term price targets offered by three analysts, the average price target for SOPHiA GENETICS SA comes to $8.33. The forecasts range from a low of $7.00 to a high of $10.00. The average price target represents an increase of 64.62% from the last closing price of $5.06.
Analyst Price Targets (3 )
Broker Rating
SOPHiA GENETICS SA currently has an average brokerage recommendation (ABR) of 1.38 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by four brokerage firms. The current ABR compares to an ABR of 1.38 a month ago based on four recommendations.
Of the four recommendations deriving the current ABR, two are Strong Buy and two are Buy. Strong Buy and Buy respectively account for 50% and 50% of all recommendations. A month ago, Strong Buy made up 50%, while Buy represented 50%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 |
Buy | 2 | 2 | 2 | 2 | 2 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.38 | 1.38 | 1.38 | 1.38 | 1.38 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
1/19/2024 | BTIG | Mark Massaro | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.38 |
ABR (Last week) | 1.38 |
# of Recs in ABR | 4 |
Average Target Price | $8.33 |
LT Growth Rate | NA |
Industry | Medical Info Systems |
Industry Rank by ABR | 91 of 252 |
Current Quarter EPS Est: | -0.28 |